A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors
Sun, Weijing, Stevenson, James P., Gallagher, Maryann, Giantonio, Bruce, Algazy, Kenneth, Haller, Dan, Vaughn, David, Raskay, Barbara J., O'Dwyer, Peter J.
Published in Cancer (15.07.2001)
Published in Cancer (15.07.2001)
Get full text
Journal Article